Published in J Clin Exp Hepatol on January 06, 2015
Small bowel varices secondary to chronic superior mesenteric vein thrombosis in a patient with heterozygous Factor V Leiden mutation: a case report. J Med Case Rep (2015) 0.77
An Unusual Case of Gastrointestinal Bleeding from Isolated Gallbladder Varices in a Patient with Pancreatic Cancer Complicated by Portal Biliopathy. Case Rep Gastrointest Med (2016) 0.75
Transsplenic portal vein reconstruction-transjugular intrahepatic portosystemic shunt in a patient with portal and splenic vein thrombosis. Radiol Case Rep (2016) 0.75
Hepatobiliary Quiz (Answers)-15 (2015). J Clin Exp Hepatol (2015) 0.75
Portal vein thrombosis in patients with cirrhosis. Gastroenterol Rep (Oxf) (2017) 0.75
Mesenteric venous thrombosis. N Engl J Med (2001) 5.87
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology (2012) 5.75
Venous thrombosis: a multicausal disease. Lancet (1999) 5.41
Vascular disorders of the liver. Hepatology (2009) 5.38
Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol (2012) 4.62
Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology (1992) 4.22
Treatment of acute portal vein thrombosis by nontraditional anticoagulation. Hepatology (2014) 4.04
Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol (2005) 3.68
Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology (2008) 3.52
Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology (2000) 3.16
Biliary abnormalities associated with extrahepatic portal venous obstruction. Hepatology (1993) 3.08
Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation (2000) 2.90
Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology (2010) 2.82
Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology (2001) 2.75
Portal vein grafts in hepatic transplantation. Surg Gynecol Obstet (1985) 2.59
Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study. Hepatology (2003) 2.43
Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology (2000) 2.34
Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study. Hepatology (2013) 2.30
Splenic and portal venous obstruction in chronic pancreatitis. A prospective longitudinal study of a medical-surgical series of 266 patients. Dig Dis Sci (1992) 2.26
Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review. Transplantation (2012) 2.26
De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes. Am J Gastroenterol (2013) 2.22
The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. Blood (2008) 2.21
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol (2009) 2.14
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol (2010) 2.11
Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology (1985) 2.11
Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol (2006) 1.95
Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int (2012) 1.87
Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut (2001) 1.86
Prevalence of spontaneous hepatofugal portal flow in liver cirrhosis. Clinical and endoscopic correlation in 228 patients. Gastroenterology (1991) 1.82
Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol (2007) 1.82
Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders. Gastroenterology (1988) 1.76
Pseudosclerosing cholangitis in extrahepatic portal venous obstruction. Gut (1992) 1.74
The role of anticoagulation in pylephlebitis. Am J Surg (1996) 1.71
A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Arch Intern Med (2000) 1.70
Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol (2006) 1.66
Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut (2005) 1.65
Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis. Radiology (2012) 1.65
Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol (2005) 1.64
Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol (2004) 1.62
Coagulation abnormalities in malignancy: a review. Semin Thromb Hemost (1992) 1.61
Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. J Vasc Interv Radiol (2005) 1.60
Review article: portal vein thrombosis -- new insights into aetiology and management. Aliment Pharmacol Ther (2005) 1.59
Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis. Cardiovasc Intervent Radiol (2006) 1.56
Endoscopic treatment of esophagogastric variceal bleeding in patients with noncirrhotic extrahepatic portal vein thrombosis: a long-term follow-up study. Gastrointest Endosc (2008) 1.56
Extrahepatic portal hypertension. A retrospective analysis of 127 cases and associated clinical implications. Arch Surg (1974) 1.53
Natural history of bleeding after esophageal variceal eradication in patients with extrahepatic portal venous obstruction; a 20-year follow-up. Indian J Gastroenterol (2010) 1.52
Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology (2006) 1.51
Biliary changes in extrahepatic portal venous obstruction: compression by collaterals or ischemic? Gastrointest Endosc (1999) 1.44
Clinical features, diagnosis and outcome of acute portal vein thrombosis. QJM (2000) 1.37
Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol (2010) 1.35
Portal thrombosis in cirrhotics. A retrospective analysis. Ann Surg (1986) 1.35
Vascular complications after orthotopic liver transplantation. Am J Surg (1991) 1.33
Endoscopic management of biliary obstruction caused by cavernous transformation of the portal vein. Gastrointest Endosc (2003) 1.31
Portal hypertension due to portal venous thrombosis: etiology, clinical outcomes. World J Gastroenterol (2007) 1.30
Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol (2004) 1.29
Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis. Blood (2012) 1.29
Cholangiopathy associated with portal hypertension: diagnostic evaluation and clinical implications. Gastrointest Endosc (1999) 1.29
Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology (2000) 1.27
Liver transplantation in patients with portal vein thrombosis. Liver Transpl (2001) 1.23
The treatment responses in cases of radiation therapy to portal vein thrombosis in advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys (2008) 1.18
Etiological spectrum of esophageal varices due to portal hypertension in Indian children: is it different from the West? J Gastroenterol Hepatol (2007) 1.18
Percutaneous transhepatic treatment of symptomatic mesenteric venous thrombosis. J Vasc Surg (2002) 1.17
Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology (2005) 1.17
Nonmalignant portal vein thrombosis in adults. Nat Clin Pract Gastroenterol Hepatol (2006) 1.17
Vascular complications in acute pancreatitis assessed by color duplex ultrasonography. Pancreas (2000) 1.17
Treatment of portal venous thrombosis with selective superior mesenteric artery infusion of recombinant tissue plasminogen activator. J Vasc Surg (2003) 1.15
Surgical guidelines for the management of extra-hepatic portal vein obstruction. Pediatr Transplant (2006) 1.13
Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol (2007) 1.13
Applications of percutaneous mechanical thrombectomy in transjugular intrahepatic portosystemic shunt and portal vein thrombosis. Tech Vasc Interv Radiol (2003) 1.13
Portal vein thrombosis. Hepatobiliary Pancreat Dis Int (2005) 1.12
Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective study. J Gastroenterol Hepatol (2012) 1.12
Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from Western India. Hepatology (2001) 1.11
Thrombolytic treatment of portal thrombosis. Hepatogastroenterology (2003) 1.10
Biliary varices on endoscopic ultrasonography: clinical presentation and outcome. Endoscopy (2000) 1.10
Thrombophilic conditions in non-cirrhotic portal vein thrombosis. Indian J Gastroenterol (2005) 1.10
Portal vein thrombosis, cirrhosis, and liver transplantation. J Hepatol (2012) 1.09
Sonographic features of portal vein thrombosis. AJR Am J Roentgenol (1985) 1.08
The prevalence and spectrum of colonic lesions in patients with cirrhotic and noncirrhotic portal hypertension. Hepatology (1995) 1.08
Prevalence of inherited antithrombin, protein C, and protein S deficiencies in portal vein system thrombosis and Budd-Chiari syndrome: a systematic review and meta-analysis of observational studies. J Gastroenterol Hepatol (2013) 1.07
Preoperative contralateral portal vein embolization before major hepatic resection is a safe and efficient procedure: a large single institution experience. Surgery (2008) 1.07
Portal vein thrombosis: imaging findings. AJR Am J Roentgenol (1994) 1.06
Management of portal vein thrombosis in liver transplantation: influence on morbidity and mortality. Clin Transplant (2007) 1.06
Contrast-enhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous systems. AJR Am J Roentgenol (2006) 1.04
Detection of thrombosis in the portal venous system: comparison of contrast-enhanced MR angiography with intraarterial digital subtraction angiography. Radiology (2000) 1.03
Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a case cohort study. J Gastroenterol Hepatol (2008) 1.03
Meta-analysis: the significance of screening for JAK2V617F mutation in Budd-Chiari syndrome and portal venous system thrombosis. Aliment Pharmacol Ther (2011) 1.02
Portal vein thrombosis following splenectomy: identification of risk factors. Am Surg (2003) 1.01
Diagnosis of portal vein thrombosis: value of color Doppler imaging. AJR Am J Roentgenol (1991) 1.01
Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms. J Thromb Haemost (2011) 1.01
Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma. World J Gastroenterol (2008) 1.01
Spectrum of portal vein thrombosis in the West. J Gastroenterol Hepatol (2002) 1.01
Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of venous symptomatic chronic portal thrombosis in non-cirrhotic patients. Cardiovasc Intervent Radiol (2004) 1.01
Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma. Eur Radiol (2008) 1.01
Treatment of extrahepatic portal hypertension in children by mesenteric-to-left portal vein bypass: a new physiological procedure. Eur J Surg (1999) 1.00
Portal vein thrombosis (PVT): a study of 20 non-cirrhotic cases. Swiss Med Wkly (2005) 1.00
Pregnancy in women with portal vein thrombosis: results of a multicentric European study on maternal and fetal management and outcome. J Hepatol (2012) 1.00
Catheter-directed thrombolysis with transjugular access in portal vein thrombosis secondary to pancreatitis. Eur J Radiol (2001) 1.00
Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosis. Clin Imaging (2003) 0.99
HLA DRB1 Alleles Discriminate the Manifestation of Autoimmune Hepatitis as Type 1 or Type 2 in North Indian Population. J Clin Exp Hepatol (2013) 0.75